TRAF2 anticorps (N-Term)
Aperçu rapide pour TRAF2 anticorps (N-Term) (ABIN201466)
Antigène
Voir toutes TRAF2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- Recognizes human TRAF2. Species cross-reactivity: mouse and rat.
-
Purification
- Immunoaffinity purified
-
Immunogène
-
Synthetic peptide TRAF2 16aa near the amino terminus of human TRAF2 (Genbank accession No. CAI15106).
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Indications d'application
-
Approved: WB (0.5 - 1 μg/mL)
Usage: Suitable for use in Western Blot. Western Blot: 0.5-1 μg/mL. Positive control: Human liver tissue lysate. -
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.2, 0.02 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
-
Short term: 4°C
Long term: Add glycerol (40-50%) -20°C.
-
-
- TRAF2 (TNF Receptor-Associated Factor 2 (TRAF2))
-
Autre désignation
- TRAP / TRAF2
-
Sujet
-
Name/Gene ID: TRAF2
Synonyms: TRAF2, MGC:45012, TRAP3 -
ID gène
- 7186
-
UniProt
- Q12933
-
Pathways
- Signalisation NF-kappaB, Apoptose, Caspase Cascade in Apoptosis, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Positive Regulation of Endopeptidase Activity, Hepatitis C, Unfolded Protein Response, S100 Proteins
Antigène
-